The Container Store vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Specialty retailer of storage and organization products with ~100 stores. Emerged from Chapter 11 in Jan 2025; being acquired by Bed Bath & Beyond for $150M.
About
The Container Store is an American specialty retailer founded in 1978 and headquartered in the Dallas-Fort Worth area, focused exclusively on storage and organization products for home and office environments. As the category's originating retailer, the company built its brand over four decades around a curated assortment of containers, shelving systems, closet organizers, and organizational accessories sourced from around the world, combined with a service model emphasizing deep product knowledge among its store associates.\n\nThe company operates approximately 100 retail locations across the United States, offering both branded product lines and exclusive designs developed in partnership with suppliers. Its custom closet and storage system business — anchored by the TCS Closets product line — represents a higher-margin, design-led offering that differentiates it from mass-market home goods retailers. The Container Store has historically cultivated strong customer loyalty through its expert-staffed store experience and its positioning as the definitive destination for solving organizational challenges.\n\nAfter filing for Chapter 11 bankruptcy protection, The Container Store emerged from restructuring in January 2025. The company is being acquired by Beyond Inc., the parent company of the Bed Bath and Beyond brand, in a transaction that would integrate The Container Store into a broader home goods portfolio. The acquisition reflects Beyond Inc.'s strategy of assembling a digital-first home goods platform anchored by brands with strong customer recognition, while The Container Store gains a path to financial stability and potential e-commerce scale under new ownership.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.